New York Halts Medicaid Enrollment for Pharmacies, Labs for 6 Months
New York imposes a six-month Medicaid enrollment moratorium starting July 30, 2026, affecting pharmacies, labs, and other providers.
Why it matters: This moratorium affects key Medicaid providers like pharmacies and labs, requiring legal and compliance teams to reassess enrollment and ownership policies amid federal scrutiny and program integrity concerns.
- Announced by New York Medicaid Director Amir Bassiri on July 30, 2026.
- Applies specifically to pharmacies, laboratories, licensed home care service agencies, durable medical equipment suppliers, applied behavioral analysts, and managed long-term care plans.
- Moratorium freezes new Medicaid enrollments and changes of ownership for affected providers.
- Implemented in response to federal Centers for Medicare & Medicaid Services (CMS) program integrity concerns.
On July 30, 2026, New York State Medicaid Director Amir Bassiri announced a six-month moratorium on new Medicaid provider enrollments and ownership changes for six high-risk provider categories. These categories include pharmacies, laboratories, licensed home care service agencies, durable medical equipment suppliers, applied behavioral analysts, and managed long-term care plans.
Bassiri stated the moratorium addresses program integrity concerns identified by the Centers for Medicare & Medicaid Services (CMS). CMS flagged these provider types as vulnerable to fraud, waste, and abuse, prompting New York to implement this preventive measure.
The moratorium prohibits both new Medicaid enrollments and ownership changes such as mergers, acquisitions, or transfers within the affected categories. This restriction could impact providers planning corporate restructuring or expansion through ownership changes during the six-month period.
The New York State Department of Health has formally communicated the moratorium to impacted stakeholders through official channels, emphasizing its temporary nature with a conclusion expected around January 30, 2027.
For legal and compliance professionals, this development means reassessing provider enrollment strategies and ownership transactions to ensure adherence to the moratorium. Providers must monitor regulatory updates closely to manage operational risks and maintain Medicaid participation throughout the duration.
Similar moratoria on Medicaid enrollment for high-risk providers have been enacted by CMS nationwide to enhance Medicaid program integrity.
By the numbers:
- 6 months — duration of new enrollment and ownership change moratorium
- 6 provider categories — including pharmacies and laboratories affected
- July 30, 2026 — moratorium announcement date by New York State Medicaid Director
What's next: The moratorium is set to expire around January 30, 2027, pending further review or extension depending on CMS guidance and New York Medicaid assessments.